Statistics

Total Visits

Views
FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-alpha blockers in psoriatic arthritis: A longitudinal study with 6 months of followup97

Select a period of time:

Number of views in the range

Views
FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-alpha blockers in psoriatic arthritis: A longitudinal study with 6 months of followup26

Views

Views
November 20251
December 20256
January 20263
February 20260
March 20268
April 20265
May 20263
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
United Kingdom6
Brazil2
Angola1
Argentina1
China1
Germany1
Spain1
Mauritius1
Peru1
 

Top cities views

Views
Araras1
Ashburn1
Brooklyn1
Carapicuíba1
Córdoba1
Hoffman Estates1
Istanbul1
Lima1
Los Angeles1
Luanda1